Genova Clinical Research Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Tucson AZ United States (2005)
Status: Defunct (2014)

Organization Overview

First Clinical Trial
2009
NCT01038843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Genova Diagnostics

Active Ingredients

Drugs in Phase 4 Trials (3)

bifidobacterium infantis (1 trial)

nitazoxanide (Alinia) (1 trial)

pancrelipase (creon) (1 trial)

Drugs in Phase 3 Trials (1)

influenza vaccine, recombinant hemagglutinin (1 trial)

Drugs in Phase 2 Trials (1)

fedovapagon (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 3)

Irritable Bowel Syndrome (Phase 4)

Nocturia (Phase 2)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5